Versão HTML básica
391
Use of antifungal drugs in hematology
Rev Bras Hematol Hemoter. 2012;34(5):383-91
51. Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat
Y, Coignard B, Dromer F, Bretagne S, Suarez F, Mahlaoui N, Bougnoux
ME, Lortholary O, Poirot JL, Isnard F, Dannaoui E, Guillemain R,
Cordonnier C, Pautas C, Hicheri Y, Foulet F, Bretagne S, Lacroix C,
Ribaud P, Bergeron A, Pavie J, Raffoux E, Brethon B, Quinio D, Moalic
E, Coutureau F, Guillerm G, Fines-Guyon M, Verdon R, Gay-Andrieu F,
Moreau P, Tallarmin P, Gangneux JP, Chevrier S, Camus C, de Guibert S,
Revest M, Chandenier J, Bailly E, Bastides F, Lebeau B, Brenier-Pinchart
MP, Mallaret MR, Hamidfar R, Bosseray A, Garban F, de Monbrison F,
Thiébaut A, Nicolle MC, Michallet M; French Mycosis Study Group.
Epidemiological trends in invasive aspergillosis in France: the SAIF
network (2005-2007). Clin Microbiol Infect. 2011;17(12):1882-9.
52. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC
International Antimicrobial Therapy Cooperative Group. Am J Med.
1989;86(6 Pt 1):668-72.
53. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic
and antifungal therapy for cancer patients with prolonged fever and
granulocytopenia. Am J Med. 1982;72(1):101-11.
54. Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, et al.
Empirical versus preemptive antifungal therapy for high-risk, febrile,
neutropenic patients: a randomized, controlled trial. Clin Infect Dis.
2009;48(8):1042-51.Comment in: Clin Infect Dis. 2009;49(7):1138-9;
author reply 1139-40. Clin Infect Dis. 2009; 48(8):1052-4. Clin Infect
Dis. 2010;50(8):1201-2; author reply 1202.
55. Hebart H, Klingspor L, Klingebiel T, Loeffler J, Tollemar J, Ljungman
P, et al. A prospective randomized controlled trial comparing PCR-based
and empirical treatment with liposomal amphotericin B in patients after
allo-SCT. Bone Marrow Transplant. 2009;43(7):553-61.
56. Dignan FL, Evans SO, Ethell ME, Shaw BE, Davies FE, Dearden CE,
et al. An early CT-diagnosis-based treatment strategy for invasive fungal
infection in allogeneic transplant recipients using caspofungin first
line: an effective strategy with low mortality. Bone Marrow Transplant.
2009;44(1):51-6.
57. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K,
Verbeken E, et al. Galactomannan and computed tomography-based
preemptive antifungal therapy in neutropenic patients at high risk for
invasive fungal infection: a prospective feasibility study. Clin Infect Dis.
2005;41(9):1242-50.Comment in: Clin Infect Dis. 2005;41(9):1251-3.
Clin Infect Dis. 2006;42(10):1507-8; author reply 1508-9.
58. Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL.
Epidemiology of opportunistic fungal infections in Latin America. Clin
Infect Dis. 2010;51(5):561-70.
59. Phillips P, Shafran S, Garber G, Rotstein C, Smaill F, Fong I, Salit I,
Miller M, Williams K, Conly JM, Singer J, Ioannou S. Multicenter
randomized trial of fluconazole versus amphotericin B for treatment of
candidemia in non-neutropenic patients. Canadian Candidemia Study
Group. Eur J Clin Microbiol Infect Dis. 1997;16(5):337-45.
60. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass
C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D,
Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L,
Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin
RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG,
Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute
of Allergy and Infectious Diseases Mycoses Study Group. A randomized
and blinded multicenter trial of high-dose fluconazole plus placebo
versus fluconazole plus amphotericin B as therapy for candidemia
and its consequences in nonneutropenic subjects. Clin Infect Dis.
2003;36(10):1221-8.Comment in: Clin Infect Dis. 2003;36(10):1229-31.
61. Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards
JE, et al. A randomized trial comparing fluconazole with amphotericin
B for the treatment of candidemia in patients without neutropenia.
Candidemia Study Group and the National Institute. N Engl J Med.
1994;331(20):1325-30.Comment in: N Engl J Med. 1995; 332(16):1101.
N Engl J Med. 1994;331(20):1371-2. ACP J Club. 1995;122(2):42
62. Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH,
et al. Voriconazole versus a regimen of amphotericin B followed by
fluconazole for candidaemia in non-neutropenic patients: a randomised
non-inferiority trial. Lancet 2005;366(9495):1435-42.Comment in: Lancet.
2006;367(9512):728-9; author reply 729. Lancet. 2005;366(9495):1413-4.
63. Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A,
Chotpitayasunondh T, Konja J, Diekmann-Berndt H, Koblinger S, Groll
AH,ArrietaA, Freeman P, vonWulffen H, Klompmaker I, Lang T,Wagner
K, Beier F, Schaefer A, Grogan C, Nissen M, Colombo LA, Baldacci ER,
Filho Fde Q, Berezin EN, Lotfi CJ, Freire AT, Decruyenaere J, Grcic-
Filipovic B, Konja J, Leverger G, Makwana, Reddy NK, Raghunadharao
D, PrabhaA, Vadhiraja BM, RamasubramanianV, Kowalczyk J,Abecassis
M, Poole J, van der Vyver A, Chotpitayasunondh T, Leelarasamee A,
Pancharoen C, Heresi G, Albano E, Arrieta A.; Micafungin Invasive
Candidiasis Study Group. Micafungin versus liposomal amphotericin B
for pediatric patients with invasive candidiasis: substudy of a randomized
double-blind trial. Pediatr Infect Dis J. 2008;27(9):820-6.
64. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut?
Clin Infect Dis. 2001;33(12):1959-67.
65. Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, et al. Early
removal of central venous catheter in patients with candidemia does not
improve outcome: analysis of 842 patients from 2 randomized clinical
trials. Clin Infect Dis. 2010;51(3):295-303.Comment in: Clin Infect Dis.
2010;51(3):304-6. Clin Infect Dis. 2010;51(11):1347; author reply 1348-
50. Clin Infect Dis. 2010;51(11):1347-8; author reply 1348-50.
66. Chaussade H, Bastides F, Lissandre S, Blouin P, Bailly E, Chandenier J,
et al. Usefulness of corticosteroid therapy during chronic disseminated
candidiasis: case reports and literature review. J Antimicrob Chemother.
2012;67(6):1493-5.
67. Legrand F, Lecuit M, Dupont B, Bellaton E, Huerre M, Rohrlich PS, et
al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis.
Clin Infect Dis. 2008;46(5):696-702.
68. Slobbe L, Polinder S, Doorduijn JK, Lugtenburg PJ, el Barzouhi
A, Steyerberg EW, et al. Outcome and medical costs of patients with
invasive aspergillosis and acute myelogenous leukemia-myelodysplastic
syndrome treated with intensive chemotherapy: an observational study.
Clin Infect Dis. 2008;47(12):1507-12.
69. Nucci M, Marr KA, Queiroz-Telles F, Martins CA, Trabasso P, Costa S,
et al. Fusarium infection in hematopoietic stem cell transplant recipients.
Clin Infect Dis. 2004;38(9):1237-42.
xxx